Drugs / FU
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01068132 Background | Apr 2009 → Oct 2013 | colorectal cancer | Regione Lombardia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01068132 ↗ |
| Route | Intravenous | “FU 400 mg/m2 administered as an intravenous bolus injection” NCT01068132 ↗ |